Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research    » Alternative Medicine    » Beta Cells    » Cause    » Cells    » Children    » Complications    » Control    » Cure    » Diagnosis    » Drugs    » Elderly    » Genes    » Immune Cells    » Inhaled Insulin    » Insulin    » Islet Cells    » Neuropathy    » Obesity    » Oral Insulin    » Other Diseases    » Pets    » Pre-Diabetes    » Prevention    » Research    » Retinopathy    » Risk Factors    » Stem Cells    » Technology    » Testing    » Transplants    » Treatments    » Trials    » Type 1    » Type 2 Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Research » Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Chili Attenuates Postprandial Insulin Response Posted: Thursday, August 03, 2006

Animal and some human studies have indicated that the consumption of chili-containing meals increases energy expenditure and fat oxidation, which may help to reduce obesity and related disorders.

Once A Day Insulin As Effective as Multiple Injections For Type 2’s Posted: Friday, July 21, 2006

Patients with type 2 diabetes may be able to achieve the same glucose control with fewer injections a day.

Evening and Bedtime Second Dose Equal for Long-Acting Insulin Levemir Posted: Friday, July 14, 2006

Patients who take Levemir (insulin detemir) twice daily can chose a convenient evening time for their second dose.

Investigational Januvia (MSD) Put Through Its Paces for Diabetes Posted: Thursday, June 15, 2006

Researchers reported that, Januvia (sitagliptin), an investigational oral agent for type 2 diabetes, appears to be effective when given as a monotherapy or as an adjunct to Glucophage (metformin) or Actos (pioglitazone). FDA approval expected soon.

New Oral Insulin Shows Safety, Feasibility in Trials Posted: Thursday, June 15, 2006

In the first human trials of oral insulin, the drug acted within 15 minutes and showed 60%-70% of the biopotency of injected insulin, without causing any adverse effects, researchers reported here at the 66th Scientific Sessions of the American Diabetes Association.

A Skin Patch for Insulin Delivery Posted: Thursday, June 15, 2006

The first results from an investigational transdermal insulin delivery system suggest that it is possible to deliver insulin through the skin.

Insulin Identified as Trigger that Causes Type 1 Diabetes Posted: Tuesday, May 30, 2006

Two teams of scientists identified the hormone insulin last week as the antigeny in triggering Type 1 diabetes.

Mechanism For How The Pancreas Makes Insulin Is Crystalized Posted: Wednesday, May 24, 2006

"It is possible that the insulin deficiency happens when the crystals don't form properly and then part of the insulin that is produced gets destroyed."

Byetta Update Posted: Thursday, April 27, 2006

Eleven months later, Byetta is meeting expectations for better glucose control and weight loss in type 2 diabetics.

Little Difference Between Human Insulin And Analogs Posted: Thursday, April 27, 2006

Fast-acting artificial insulin drugs work just as well as regular human insulin, but it’s unclear how they could affect the health of people with diabetes over the long run.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.